Merck & Co Inc
NYSE: MRK
$99.65
-$1.33 (-1.3%)
Closing Price on January 14, 2025
MRK Articles
Jon OggShort sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in June and rising interest rates are obviously making short...
Published:
ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a stalking horse bid, that’s what many observers...
Published:
Last Updated:
Jon OggShort sellers have really made some big changes in their bets against the key high-yield dividend stocks that had been the darling of Wall Street. Many of these stocks are members of the Dow...
Published:
Jon OggShort sellers could have cleaned up by betting against the high dividend stocks in May and into June. Investors got a whiff of what rising interest rates might mean to their premium dividend...
Published:
This last week had much more volatility than what investors have grown used to. 24/7 Wall St. wanted to highlight the top analyst sector research calls of the week now that investors are trying to...
Published:
Last Updated:
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their...
Published:
U.S. equity markets opened higher this morning following a slightly upbeat report on eurozone manufacturing PMI. While not yet in positive territory, eurozone PMI rose as a whole and rose in most...
Published:
Last Updated:
Jon OggThe bull market appears to still be alive and well for equities, but the risk of rising interest rates is plaguing bonds and investments tied to big dividends. What equity investors also need...
Published:
Last Updated:
ThinkstockShort sellers are have previously been all over the place when it comes to the high-yield dividend stocks. The May 15 settlement date is during what should have been (or could have been) a...
Published:
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, May 28, 2013. They include Eli Lilly, W.R. Grace, Intelsat and GlaxoSmithKline.
Published:
Last Updated:
ThinkstockSony Corp. (NYSE: SNE) cuts forecasts for game console margins for the next several years. (MarketWatch) Sony also cuts targets for smartphones and camera sales. (Reuters) A complex Irish...
Published:
Last Updated:
ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for investors to consider is keep a weighting...
Published:
On the surface it looks like short sellers are all over the place in the latest short interest report. The April 30 settlement date is after many companies had their earnings reports. We saw some...
Published:
Last Updated:
U.S. equity markets opened lower this morning following a weaker-than-expected employment report from ADP and concern that Friday’s report from the Bureau of Labor Statistics will follow the ADP...
Published:
Last Updated:
Jon OggBiotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many investors, what investors need to know...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.